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e show here that the 
 

 
, 
 

 
, and 
 

 
 isotypes of
 
peroxisome proliferator–activated receptor (PPAR)
 
are expressed in the mouse epidermis during
fetal development and that they disappear progressively
from the interfollicular epithelium after birth. Interestingly,
 
PPAR
 

 
 and 
 

 
 expression is reactivated in the adult epidermis
after various stimuli, resulting in keratinocyte proliferation
and differentiation such as tetradecanoylphorbol acetate
topical application, hair plucking, or skin wound healing.
 
Using PPAR
 

 
, 
 

 
, and 
 

 
 mutant mice, we demonstrate that
W
 
PPAR
 

 
 and 
 

 
 are important for the rapid epithelialization
of a skin wound and that each of them plays a specific
 
role in this process. PPAR
 

 
 is mainly involved in the early
inflammation phase of the healing, whereas PPAR
 

 
 is im-
 
plicated in the control of keratinocyte proliferation. In
 
addition and very interestingly, PPAR
 

 
 mutant primary
keratinocytes show impaired adhesion and migration
properties. Thus, the findings presented here reveal unpre-
 
dicted roles for PPAR
 

 
 and 
 

 
 in adult mouse epidermal repair.
 
Introduction
 
The major function of the outermost layer of the skin, the
epidermis, is to provide a defense against microbial, mechan-
ical, chemical, and UV light aggressions and to protect the
organism from dehydration. The epidermis consists of several
layers of keratinocytes which undergo a vectorial differentia-
tion program as they migrate from the basal undifferentiated
layer to the outermost layer, the stratum corneum, in which
the protective cutaneous function mainly resides (Downing,
1992; Bickenbach et al., 1995; Roop, 1995). The matura-
tion of the epidermis, and thus the formation of a compe-
tent barrier against aggressions and water loss, happens in
the latest stages of fetal development to be completed before
birth
 
 
 
(Elias, 1983; Elias and Menon, 1991; Schurer and
Elias, 1991). After birth, disruption of the mature skin will
leave an opened door to infection and dehydration, a major
 
problem for heavily injured victims. In these cases, the
covering of the wound by a new epithelium, termed reepi-
thelialization, starts within hours of the injury and will
 
eventually reconstitute a fully differentiated epithelium
that is crucial for the rebuilding of a competent protective
epidermis. The reepithelialization of a wound initially in-
volves the migration of keratinocytes from the edges of the
wound and hair follicles, their proliferation, stratification,
and differentiation/maturation to form the neo-epithelium
(Woodley, 1996).
 
Address correspondence to Walter Wahli, Institut de Biologie Animale,
Université de Lausanne, Bâtiment de Biologie, CH-1015 Lausanne,
Switzerland. Tel.: (41) 21-692-41-10. Fax: (41) 21-692-41-15. E-mail:
walter.wahli@iba.unil.ch
Pascal Escher’s present address is Parke-Davis Pharmaceutical Research,
Molecular Biology, Ann Arbor, MI 48105.
Jeffrey Peters’ present address is Department of Veterinary Science, Cen-
ter for Molecular Toxicology, Pennsylvania State University, 226 Fenske
Laboratory, University Park, PA 16802.
Sharmila Basu-Modak’s present address is Department of Pharmacy and
Pharmacology, University of Bath, BA2 7AY Bath, United Kingdom.
Key words: mouse keratinocytes; PPAR gene expression; PPAR gene tar-
geted disruption; skin wound healing; nuclear hormone receptors
 800 The Journal of Cell Biology 
 
|
 
 
 
Volume 154, 2001
 
Among the various factors that influence skin matura-
tion and development, many nuclear hormone receptors
have been implicated. After binding of their respective
ligands, nuclear hormone receptors activate the transcrip-
tion of specific target genes. Various ligands for several
members of the nuclear hormone receptor family are
known to influence epidermis differentiation. Thyroid
hormones and glucocorticoids accelerate the permeability
barrier maturation of rat skin in vivo and in vitro (Aszter-
baum et al., 1993; Hanley et al., 1996a, 1997a). Estrogen
accelerates the skin barrier formation, whereas testoster-
one delays the process (Hanley et al., 1996b). Retinoids
also influence the differentiation of the epidermis, even
though the description of their functions are different
when assayed in vitro or in vivo (Imakado et al., 1995;
Saitou et al., 1995; Li et al., 2000, 2001). More recently,
Figure 1. Differential expression of the PPARs in mouse epidermis. (A) RNase protection analysis of PPAR mRNA during mouse skin develop-
ment. Total lysates of skin from day 15.5 to 18.5 embryos (E15.5–E18.5), newborn (NB), 5- and 9-d-old (5, 9), and adult mice were hybridized 
with radiolabeled probes specific for PPAR, PPAR, PPAR, and L27 mRNA (a). The amount of mRNA for each PPAR isotype was quantified 
based on the L27 mRNA amount and on the specific activity of each probe (b; n  3–6). (B) In situ hybridization analysis of PPAR expression dur-
ing fetal development. Cryosections of mouse skin from embryonic day 13.5–18.5 (E13.5–18.5) were hematoxilin and eosin stained (HE) or 
hybridized with specific antisense digoxygenin–labeled riboprobes (PPAR, , or ). (C) In situ hybridization analysis of PPAR expression during 
post natal growth. Cryosections of mouse skin from newborn (NB), 5- or 9-d-old pups (5, 9) and adult animals were hematoxilin/eosin stained 
(HE) or hybridized with specific antisense digoxygenin-labeled riboprobes (PPAR, , or ). Arrows indicate the epidermis/dermis interface. For 
both B and C, a similar pattern of expression was observed for each time point in five different mice from independent litters. Bars, 80 m.
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peroxisome proliferator–activated receptor (PPAR)* and
farnesol X–activated receptor ligands were shown to ac-
celerate epidermal development when added to fetal rat
skin explants, whereas PPAR
 

 
 ligands have no effect
(Hanley et al., 1997b, 1998). The situation seems to be
different in human keratinocytes, since only a PPAR
 

 
-
selective ligand, but not PPAR
 

 
 or 
 

 
 ligands, induced the
expression of keratinocyte differentiation markers (West-
ergaard et al., 2001). In addition, recent results suggested
that a cross talk exists between the PPAR and the choles-
terol metabolism pathways in the epidermis (Hanley et
al., 2000).
The subfamily formed by the PPARs binds fatty acids
and their derivatives as well as hypolipidemic and antidia-
betic agents and plays important roles in energy homeo-
stasis. Three isotypes have been identified (PPAR
 

 
, 
 

 
/
 

 
or FAAR or NUC1, and 
 

 
; NR1C1, NR1C2, NR1C3,
respectively; Nuclear Receptor Nomenclature Commit-
tee, 1999) in various species (
 
Xenopus
 
 laevis, rodents, hu-
man), each of them having a specific pattern of expres-
sion (for review see Desvergne and Wahli, 1999).
Consistent with a potential role of PPAR ligands in
epidermis maturation, PPARs are expressed both in rat
skin and human keratinocytes (Braissant et al., 1996;
Braissant and Wahli, 1998; Rivier et al., 1998). In skin,
RNase protection assay and in situ hybridization reveals
that PPAR
 

 
 and PPAR
 

 
 are both expressed in the epi-
dermis during embryogenesis. However, no major skin
defect has been described in PPAR
 

 
 null mice, suggesting
that PPAR
 

 
 is not essential for skin maturation in ro-
dents (Lee et al., 1995). In contrast, we show in this
study that PPAR
 

 
 and PPAR
 

 
 are crucial for rapid skin
repair in the adult animal.
 
Results
 
PPAR gene expression in the epidermis
 
PPAR gene expression in the mouse skin was analyzed by
RNase protection assay from day 15.5 of gestation until
adulthood (Fig. 1 A). Total skin extracts, including the epi-
dermis and the dermis, were prepared and PPAR mRNA
levels were analyzed using radiolabeled PPAR
 

 
-, 
 

 
-, and
 

 
-specific probes. The three PPAR isotypes were found to be
expressed both in embryonic and in postnatal developing
skin at all the stages analyzed (Fig. 1 A). Normalization (L27
and specific activities of the probes) and quantification of
the results revealed that PPAR
 

 
 is the least abundant isotype
during development, except at embryonic day 15.5. The
level of expression of PPAR
 

 
, which is 
 

 
1.5 higher than
PPAR
 

 
 at E15.5, steadily decreases until after birth. At day
15.5 of gestation, PPAR
 

 
 is the least expressed PPAR iso-
type (1.5 and 2–3 times lower than PPAR
 

 
 and PPAR
 

 
, re-
spectively). After a twofold increase during late embryonic
development, the PPAR
 

 
 expression level decreases in the
postnatal period. In the adult skin, PPAR
 

 
 and PPAR
 

 
 are
low, with PPAR
 

 
 remaining the highest expressed isotype.
To precisely localize PPAR expression in the skin, the tissue
pattern of expression of the three PPAR isotypes was assessed
on mouse skin section using in situ hybridization with specific
PPAR
 

 
, 
 

 
, and 
 

 
 digoxigenin–labeled probes. During fetal
development from embryonic day 13.5 on to the end of the
gestation, the three PPAR isotypes were expressed, generally at
relatively low levels, in the differentiating epidermis and hair
follicles (Fig. 1 B). PPAR
 

 
 and 
 

 
 were found to be expressed
in the dermis as well, although at lower levels compared with
the epidermis. PPAR
 

 
, 
 

 
, and 
 

 
 were still expressed in the
epidermis of newborn pups (Fig. 1 C), but their expression in
the interfollicular epidermis decreased after a few days of post-
natal development. In the adult mouse skin, no expression
could be detected for any of the three isotypes in the interfolli-
cular epidermis (Fig. 1 C), whereas they were still highly ex-
pressed in the hair follicle keratinocytes (not shown).
 
*Abbreviations used in this paper: AS, antisense; K6, keratin 6;
 
 
 
PPAR,
peroxisome proliferator–activated receptor; RPA, ribonuclease protection
assay;
 
 
 
S, sense; TPA, tetradecanoylphorbol acetate.
Figure 1 (continued).
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Thus, in situ hybridization revealed that the expression
of the PPARs in the adult skin, measured by ribonuclease
protection assay (RPA), is mainly due to their presence in
the hair follicles, whereas they are undetectable in the
interfollicular epidermis. The pattern of expression of
PPAR in the epidermis at embryonic and adult stage sug-
gests that the presence of the PPARs in the keratinocytes
is related to proliferation and/or differentiation during
development, rather than to the normal adult epidermis
renewal.
 
Table I. 
 
Induced keratinocyte proliferation after TPA topical application or hair plucking
PPAR
 

 
/
 

 
PPAR
 

 
/
 
	
 
Control
Mean epidermal thickness 10.8 
 

 
 
0.31 100% 12.62 
 

 
 
0.25
 
a
 
100%
Ki67 labeling 11.1 
 

 1.1 100% 14.2 
 1.0 100%
TPA application
Epidermal thickness 26.1 
 1.3a 230.6 
 10.4b 32.3 
 2.4b 271.5 
 18.2b
Ki67 labeling 24.3 
 1.3b 219.2 
 12.6 31.7 
 1.7b 223.4 
 12.5
Hair plucking
Epidermal thickness 19.9 
 0.5a 183.9 
 8.3a 29.9 
 2.0a 237.0 
 16.0a
Ki67 labeling 18.6 
 1.3a 167.6 
 12.2 24.1 
 0.9a 169.5 
 6.9
Mean epidermal thickness was measured via light microscopy using the Object Image software. Absolute (m) and relative values (% control) are both shown
(
 SEM, five microscopic fields, five different animals). The number of Ki67-positive cells was also measured using the Object Image software. Absolute
(number of Ki67-positive cells) and relative values (% control) are both shown (
 SEM, five microscopic fields, five different animals). 
aBased on the Student’s t test, the difference is statistically significant (P , 0.01).
bBased on the Student’s t test, the difference is statistically significant (P  0.05).
Figure 2. PPAR expression is upregu-
lated in SV129 adult mouse epidermis 
upon keratinocyte proliferation stimu-
lation. TPA topical application. Vehicle- 
(a–f) or TPA-treated (g–l) dorsal skin. 
Hematoxilin/eosin (HE) staining (a and 
g); Keratin 6 (b and h) and Ki67 (c and i) 
immunolabeling; in situ hybridization 
with PPAR (d and j), PPAR (e and k), 
and PPAR (f and l) antisense probes 
(ASense); in situ hybridization of TPA-
treated samples with sense control 
probes are shown (m–o). (B) Hair pluck-
ing. Unplucked (a–f) or plucked (g–l) 
dorsal skin. Hematoxilin/eosin (HE) 
staining (a and g); Keratin 6 (b and h) 
and Ki67 (c and i) immunolabeling; in 
situ hybridization with PPAR (d and j), 
PPAR (e and k), and PPAR (f and l) 
antisense probes (ASense); in situ 
hybridization of plucked samples with 
sense control probes are shown (m–o). 
Arrows indicate the epidermis/dermis 
interface. For both A and B, similar 
results were observed in six SV129 mice 
from independent litters. Bars, 80 m.
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PPAR expression is upregulated in vivo upon 
stimulation of keratinocyte proliferation
To address the hypothesis that the expression of PPARs in
the epidermis is related to keratinocyte proliferation, we
looked at their expression in the adult mouse epidermis after
stimulation of keratinocyte proliferation either by topical
application of tetradecanoylphorbol acetate (TPA) or by hair
plucking. If PPARs are involved in keratinocyte proliferation
and/or differentiation, their expression might be reactivated
by these stimuli.
TPA applied on the dorsal skin of SV129 mice induced
thickening of the epidermis within 48 h, whereas no change
was observed on the vehicle-treated control samples. Histo-
logical staining of the TPA-treated skin showed a typical in-
crease in keratinocyte stratification compared with the con-
trol (Fig. 2 A, and Table I). As markers for keratinocyte
proliferation, we used the expression of both keratin 6 (K6)
cytoskeletal protein (Navarro et al., 1995) and the Ki67 nu-
clear antigen. As shown in Fig. 2 A, K6 immunolabeling re-
mained negative in the ethanol-treated control epidermis,
whereas high levels were detected in the epidermis after TPA
application, confirming that this agent induced the expected
proliferation of the keratinocytes. Consistent with this, the
number of Ki67-positive cells in the basal layer was also in-
creased in the TPA-treated samples (Fig. 2 A, and Table I).
In situ hybridization with PPAR-, -, and -specific
probes revealed that PPAR expression was significantly up-
regulated in the TPA-treated epidermis, whereas only a faint
signal was detected for PPAR and no signal for PPAR
(Fig. 2 A). Consistent with the results shown in Fig. 1 C,
none of the three PPAR isotypes was detected in the inter-
follicular epidermis of the control sample.
In a second approach, hairs from a small surface of dorsal
skin of SV129 mice were gently plucked, and the prolifera-
tive effect on keratinocytes was checked by histological
staining, K6 and Ki67 immunolabeling (Fig. 2 B). In con-
trast to the unplucked control skin, the epidermis of the
plucked surface showed both an increased stratification of
the keratinocytes and a strong induction of Ki67 and K6 ex-
pression (Fig. 2 B, and Table I). Similar to TPA treatment,
PPAR expression was markedly upregulated as a result of
hair plucking, whereas PPAR showed only a weak increase
Figure 2 (continued).
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and PPAR remained undetectable as analyzed by in situ
hybridization.
Thus, the marked increase in PPAR expression under
conditions inducing keratinocyte proliferation and stratifica-
tion provides a strong indication that PPAR might be di-
rectly implicated in these processes.
Generation of PPAR and  mutant mice
To study each PPAR function in the skin in vivo, we used
PPAR mutant mice. The PPAR null mouse has been de-
scribed previously (Lee et al., 1995) and we generated
PPAR and PPAR mutant animals (unpublished data).
Early embryonic lethality of PPAR null mutants was ob-
served, as also reported recently by others (Barak et al.,
1999; Kubota et al., 1999). Similarly, due to incomplete but
very high penetrance of a lethal phenotype, only few PPAR
null mice could be obtained but no null mice line could be
established so far. Similar difficulties in generating PPAR
homozygous null animals was also described recently by Pe-
ters et al. (2000); although, in that case, a PPAR knock out
line was finally obtained on a different genetic background.
Therefore, and due to the above-mentioned difficulties in
obtaining homozygous null mice, we used heterozygous
PPAR and PPAR mice in our experiments.
For each mouse line, the PPAR mRNA and protein levels
were analyzed by RNase protection assay and Western blot.
The amounts of PPAR and PPAR mRNA and protein are
decreased by half in the PPAR and PPAR/	 mice, re-
spectively, with no compensation by the other PPAR iso-
types (Table II and data not shown).
Increased keratinocyte proliferative response in 
PPAR/	 mice
To test the hypothesis of a PPAR implication in the control
of keratinocyte proliferation, we used the above mentioned
PPAR/	 mutant mice. As shown in Fig. 3 A, these het-
erozygous mice showed a normal skin architecture upon his-
tological staining. However, a careful examination of the epi-
dermal thickness and of the keratinocyte proliferation rate
indicate a slight but significant increase of both parameters in
the PPAR/	 mice compared with the wild-type control
animals (Table I). Thus, if PPAR and keratinocyte prolifer-
ation are linked, the latter might be affected in the mutant
heterozygous animals after proliferation stimuli. Therefore,
we performed a TPA stimulation on the dorsal epidermis of
PPAR/	 and control wild-type mice. As shown in Fig. 3
A, a hyperplasia of the TPA-treated epidermis occurred as ex-
pected in control mice. Compared with the wild-type con-
trol, the PPAR/	 mice showed a more pronounced strat-
ification of the epidermis. Confirming the morphological
observation, the K6 and Ki67 induction in the epidermis was
higher in the PPAR mutant mice than in the wild-type ani-
mals (Fig. 3 A, and Table I). The higher proliferative re-
sponse of the keratinocytes in the epidermis of the PPAR/	
mice was also observed after hair plucking of the dorsal skin
(Fig. 3 B, and Table I). Thus, in both assays, the proliferative
response of the keratinocytes was significantly higher in the
heterozygous mice compared with the wild-type control
(Table I). These data provide further evidence for PPAR
involvement in the control of keratinocyte proliferation.
PPAR, on the contrary, does not seem to be involved in this
mechanism, as the TPA stimulation on dorsal skin induced
identical epidermis hyperplasia in both PPAR wild-type
control and PPAR	/	 mice (data not shown).
Epidermal differentiation and hair follicle cycle are not 
affected in PPAR/	 mice
Because PPAR is expressed in the epidermis during fetal
and postnatal development (Fig. 1), and because of its in-
volvement in the control of keratinocyte proliferation (Fig.
3), the question was raised whether the differentiation pro-
cess would also be affected in the epidermis of PPAR mu-
tant mice. To address this question, the skin morphology
and the pattern of expression of several keratinocyte differen-
tiation markers (keratins 14 and 10, loricrin, involucrin)
were analyzed in the epidermis of PPAR mutant mice from
day 14.5 of gestation until adulthood. As shown after histo-
logical staining, the PPAR mutant mice show normal skin
architecture, both during fetal development (embryonic day
14.5 and 16.5, data not shown; embryonic day 18.5, Fig. 4)
and at the adult stage (Fig. 4). Immunofluorescent labelings
revealed that the pattern and the time course of expression of
Table II. PPAR expression level in PPAR and PPAR mutant mouse lines
Brain Kidney Liver
PPAR/ PPAR/	 PPAR/ PPAR/	 PPAR/ PPAR/	
PPAR RNA NA NA 0.33 0.29 0.29 0.30
PPAR RNA 0.67 (100%) 0.33 (49.2%) 0.51 (100%) 0.29 (56.8%) 0.25 (100%) 0.18 (72%)
PPAR protein 1.2 (100%) 0.51 (42.5%) 13.0 (100%) 5.8 (44.6%) 8.1 (100%) 4.1 (50.6%)
PPAR RNA NA NA 0.013 0.018 0.012 0.018
Liver Muscle WAT
PPAR/ PPAR/	 PPAR/ PPAR/	 PPAR/ PPAR/	
PPAR RNA 0.39 0.31 0.064 0.064 NA NA
PPAR RNA 0.26 0.28 0.071 0.071 0.162 0.136
PPAR RNA 0.017 (100%) 0.007 (41.2%) 0.011 (100%) 0.006 (54.5%) 1.175 (100%) 0.696 (59.2%)
PPAR protein NA NA NA NA 2.6 (100%) 1.1 (42.3%)
Table II shows the quantification of PPAR, , and  RNA and of PPAR and PPAR protein levels in the PPAR and PPAR mutant mouse lines, respectively.
The results represent the normalized values obtained after quantification of the RNase protection assays and Western blots (not shown). In parentheses:
percentage decrease of PPAR and PPAR expression compared to the wild-type control samples (100%) in the PPAR and PPAR mutant mouse lines,
respectively.
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the above mentioned differentiation markers was similar in
the PPAR mutant and the wild-type control epidermis
(Fig. 4 and data not shown).
Since PPAR is present in the hair follicle during fetal de-
velopment and remains highly expressed in this epithelial
appendage at the adult stage, the hair follicle cycle was com-
pared between PPAR heterozygous and wild-type mice in
unchallenged skin and after hair plucking. Similarly to the
expression of differentiation markers, no defect was observed
in the hair growing or in the structure of the hair follicles of
PPAR mutant mice (data not shown).
These observations suggest that one functional PPAR al-
lele is sufficient to maintain normal fetal and postnatal epi-
dermal development in the PPAR mutant mice, or that
PPARs may have redundant functions in terms of epithelial
differentiation.
PPAR gene expression in a wounded epidermis
In addition to the link between PPAR and keratinocyte
proliferation, the expression patterns of the three PPAR iso-
types suggest that they are most likely associated with epi-
dermal fetal maturation. Thus, we studied PPAR expression
during skin wound healing, an extreme situation in which
the adult skin has to regenerate a neoepidermis. This epider-
mal repair includes both hyperproliferation of the kerati-
nocytes and differentiation of a new epithelium upon clo-
sure of the wound.
A half centimeter square, full thickness skin biopsy was ex-
cised from the back of adult mice, and PPAR expression was
assessed by in situ hybridization at several time points after
the injury at the site of the wound (Fig. 5). In situ hybridiza-
tion revealed that PPAR and PPAR are both upregulated
in the epidermis of the wound edges, compared with a nor-
mal adult epidermis where they cannot be detected. PPAR
reactivation was detected as early as 24 h after the injury.
Furthermore, it remained expressed in the epidermis of the
wound edges and in the neoepithelium during the whole
healing process. After closure of the wound, PPAR was
downregulated and it became undetectable 20 d after injury.
In contrast, PPAR expression was observed during a short
Figure 3. Enhanced keratinocyte proliferative response in PPAR/	 upon stimulation. (A) TPA topical application. (a–f) PPAR/ vehi-
cle (a–c) or TPA-treated (d–f) dorsal epidermis, hematoxilin/eosin staining (HE) (a and d), and after keratin 6 (b and e) or Ki67 (c and f) immu-
nostaining. (g–l) PPAR/	 vehicle– (g–i) or TPA-treated (j–l) dorsal epidermis, hematoxilin/eosin staining (HE) (g and j), and after keratin 6 
(h and k) or Ki67 (i and l) immunostaining. (B) Hair plucking. (a–f) PPAR/ unplucked (a–c) or plucked (d–f) dorsal epidermis, hematoxi-
lin/eosin staining (HE) (a and d), and after keratin 6 (b and e) or Ki67 (c and f) immunostaining. (g–l) PPAR/	 unplucked (g–i) or plucked 
(j–l) dorsal epidermis, hematoxilin/eosin staining (HE) (g and j), and after keratin 6 (h and k) or Ki67 (i and l) immunostaining. Arrows indicate 
the epidermis/dermis interface. Bars, 80 m.
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period of time only, 3 d after the injury, and was not ob-
served thereafter. The third isotype, PPAR, was hardly de-
tectable, which suggests modest or no implication of this
isotype in the skin wound–healing process.
The differential upregulation of both PPAR and  in the
epidermis of the wound edges suggests that each of them
may play a specific role during the wound-healing process.
PPAR	/	 and /	, but not PPAR mutant mice, 
exhibit altered skin wound healing
The respective roles of PPAR, , or  during cutaneous
wound healing were assessed by measuring the efficiency of
the healing of a full thickness wound in PPAR, , or 
mutant mice.
As described above, a dorsal skin biopsy was excised on
adult mice, the surfaces of the wounds were measured until
complete healing, and the effect of either the PPAR, , or 
mutation was addressed by comparing the kinetics of wound
healing in transgenic and normal littermates. In all the mice,
either transgenic or wild-type controls, the reepithelialization
was preceded by the formation of a scab, decrease of the
wound surface, and loss of the scab upon healing of the
wound. A significant degree of strain variability was observed
in the wound closure kinetics of the control animals of the
three strains of mice. This observation is in agreement with
reports on healing of skin wounds, in which initial closure
(1 d after the biopsy) of wild-type control animals varied
from 10–60%, depending on the mouse strain (Kaya et al.,
1997; Crowe et al., 2000; Gallucci et al., 2000; Streit et al.,
2000; Echtermeyer et al., 2001). Due to this variation, only
the differences in wound healing between mutant and their
wild-type counterparts of each strain has been analyzed.
The PPAR/	 heterozygous mice were not different
from wild-type littermates in their wound-healing process
Figure 4. Normal keratinocyte-termi-
nal differentiation in PPAR/	 skin. 
(a–f) PPAR/ fetal (E18.5) (a–c) or 
adult (d–f) dorsal epidermis, hematoxi-
lin/eosin staining (HE) (a and d), and af-
ter involucrin (b and e) or loricrin (c and 
f) immunostaining. (g–l) PPAR/	 fetal 
(E18.5) (g–i) or adult (j–l) dorsal epider-
mis, hematoxilin/eosin staining (HE) 
(g and j), and after involucrin (h and k) 
or loricrin (i and l) immunostaining. 
Arrows indicate the epidermis/dermis 
interface. Bars, 40 m.
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(Fig. 6 A), which is consistent with PPAR being hardly de-
tectable after injury.
Compared with their wild-type counterparts, PPAR	/	
mice showed a delay in wound healing during the first 4 d
after injury (Fig. 6 B), as the surface of the wounds on the
PPAR	/	 mice decreased more slowly than for the wild-
type control mice. The healing efficiency was then restored
and the resolution of the healing process finally happened
within the same delay in both control and null mice. This
difference in the healing efficiency was observed both with
young (6–8 wk) and old (12–18 mo) mice, suggesting that
the phenotype is independent of the age of the animals. Ad-
ditionally, a similar phenotype was observed in mice express-
ing a PPAR dominant negative transgene specifically in the
epidermis (unpublished data). Interestingly, the initial and
transient delay observed for the healing of the PPAR null
mice correlates with the window of PPAR-increased ex-
pression during the tissue repair process, and corresponds to
the inflammatory phase of wound healing (see Figs. 5, 6 B,
and 7). Therefore, we assessed the inflammatory infiltration
in PPAR/ and 	/	 mice by quantification of the
number of neutrophils and monocytes/macrophages present
in the wound bed at day 1, 3 and 5 postwounding. As
shown in Table III, both the recruitment of neutrophils and
monocytes is impaired in the PPAR	/	 at day 1 post-
wounding. The difference in the recruitment of these im-
mune cells disappears after a few days, allowing for the resto-
ration of normal repair in the PPAR	/	 mice.
The healing kinetics obtained with the PPAR/	 het-
erozygous mice were different from the one described above
for PPAR	/	 mice. The healing of the PPAR/	 mice
was delayed during the whole repair process compared with
their wild-type littermates (Fig. 6 C), and final closure was
postponed by 2–3 d. With respect to the cascade of events
implicated in the closure of a skin wound (Fig. 7), a delay
Figure 5. Differential expression of PPAR in adult mouse epidermis during cutaneous wound closure. Cryosections of mouse skin from day 
1 to 10 (1 to 10) after the excision of a full thickness dorsal skin biopsy were hematoxilin/eosin stained (HE) or hybridized with specific 
antisense digoxygenin-labeled riboprobes (PPAR, , or ). Arrows indicate the epidermis/dermis interface. A similar pattern of expression 
was observed for each time point in six different mice from independent litters. Bar, 80 m.
Table III. Inflammatory infiltrate in the wound bed of PPAR
wild-type and null mice
Day
postwounding
Neutrophil
number
Monocyte/macrophage
number
PPAR/ PPAR	/	 PPAR/ PPAR	/	
1 76.1 
 5.5 63.6 
 2.5a 12.4 
 0.8 27.8 
 3.1b
3 50.3 
 6.0 40.5 
 3.4 51.2 
 2.8 54.4 
 2.1
5 16.1 
 2.2 11.6 
 1.0 50.0 
 3.3 47.7 
 2.5
The number of neutrophils and of monocytes/macrophages present in the
wound bed at day 1, 3, and 5 postwounding was assessed based on
morphological criteria in PPAR wild-type and null mice. The values
represent the mean of the number of cells counted in five standardized
microscope fields per section, performed on three different animals for each
stage postwounding, 
 SEM.
aBased on a Student’s t test, the difference is statistically significant (P  0.05).
bBased on a Student’s t test, the difference is statistically significant (P  0.01).
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observed during the whole process suggests either a default
in skin elasticity and contraction of the wound, or an im-
paired keratinocyte migration/proliferation. To test the first
possibility, elastin- and collagen-specific stainings and dorsal
incisional wounds were made on PPAR/	 and wild-type
mice. In unchallenged adult skin, the elastin and collagen
deposits were similar in the PPAR wild-type and mutant
dermis (Fig. 8). Moreover, the time course of collagen accu-
mulation in the granulation tissue during the healing of
a wound is identical in the PPAR/	 mice compared
with the wild-type controls (Fig. 8). Finally, the incisional
wounds remained perfectly linear in both genotypes, indi-
Figure 6. PPAR and  mutant mice are unable to sustain normal 
wound healing. (A–C) After excision of a full thickness skin biopsy, 
the surfaces of the healing wounds were measured over time on 
wild-type (/), heterozygous (/	), or null (	/	) mice: PPAR 
(A), PPAR (B), and PPAR (C). The surfaces are plotted as a per-
centage of the surface of the wound at day zero (
 SEM, n  8–10). 
Asterisks indicate that the difference is statistically significant 
(asterisk, P  0.05; double asterisk, P  0.01). Arrows indicate the 
mean time for complete healing of the wild-type control mice (black 
lozenge) or transgenic mice (grey square).
Figure 7. PPAR  and  expression and 
respective mice phenotypes compared 
with the major phases of skin wound 
healing. (A) Summary of time sequence 
of the major overlapping phases of skin 
wound healing. (B) Plain lines indicate 
the expression of PPAR and  in the 
healing epidermis; dotted lines indicate 
the duration of the observed phenotype 
on PPAR mutant mice.
Functional involvement of PPARs in mouse skin repair | Michalik et al. 809
cating that skin elasticity is not impaired in the heterozygous
mice (data not shown) and that the healing delay is not due
to a loss of skin elasticity in the mutated animals.
Since the hypothesis of a defect in PPAR/	 skin elas-
ticity was unlikely, the adhesion and migration capacities of
the PPAR-mutated keratinocytes were studied in vitro us-
ing primary keratinocyte cultures. Keratinocytes were iso-
lated from the skin of wild-type and PPAR/	 newborn
pups. PPAR mutant keratinocytes in culture immediately
showed impaired adhesion capacities: they adopted a rounded
shape and only adhered 4 d after seeding, whereas the wild-
type primary keratinocytes spread and adhered easily 24 h
after seeding (Fig. 9). However, despite this adhesion defect
and delay in adherence, the PPAR mutant keratinocytes re-
main viable. Seeding of more mutant keratinocytes com-
pared with the wild-type cells (see Materials and methods)
allowed us to obtain 70–80% confluent cultures for both ke-
ratinocyte genotypes, allowing the study of in vitro healing
of a scraping wound. After scraping of the culture, the wild-
type and mutant cells behaved very differently at the edges
of the in vitro wound. As shown in Fig. 9, the PPAR wild-
type keratinocytes remained in tight contact with each other
and scraping resulted in folds at the edges (Fig. 9 b). On the
contrary, the PPAR/	 keratinocytes were easier to de-
tach, and the produced edges were blunt (Fig. 9 f). Once the
PPAR wild-type keratinocytes started to migrate out of the
edges, their migration rate was higher compared with that of
the PPAR/	 keratinocytes (Fig. 9, c, d, g, and h). This
in vitro result indicates that the migration properties of the
PPAR mutant keratinocytes are impaired, consistent with
observations in whole animal. Indeed, in vivo, the number
of keratinocytes per surface unit is slightly higher at the
edges of skin wound in the PPAR mutant animals com-
pared with the wild-type mice, also indicating that in vivo as
well, the migration is slower in PPAR mutant cells (data
not shown).
In conclusion, mice with a mutated PPAR or  gene
cannot sustain normal cutaneous wound healing in a way
which indicates that PPAR is implicated preferentially dur-
ing the early stages of the process, and PPAR during the
Figure 8. Elastin and collagen deposit 
is not altered in the dermis of PPAR/	 
mice. PPAR/ (a–d) or PPAR/	 
(e–h) dorsal epidermis, elastin (a and e), 
or collagen (b–d and f–h) staining. (a, b, 
e, and f) Unchallenged adult dorsal skin. 
(c, d, g, and h) Mouse skin at day 10 and 
20 (10 and 20) after the excision of a 
full thickness dorsal skin biopsy. Arrows 
indicate the epidermis/dermis interface. 
Bar, 80 m.
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whole healing period, which correlates with their reactivated
expression pattern after skin biopsy. Moreover, the results
indicate that the recruitment of immune cells is impaired
during the early inflammatory phase in the PPAR	/	
mice, whereas the delay observed in PPAR mutant mice is
likely to be due to impaired adhesion and migration capaci-
ties of the keratinocytes.
Discussion
This work was aimed at characterizing the expression and
function of the three PPAR isotypes in the fetal and adult
skin. In short, we have demonstrated that the developing
skin expresses the three PPAR isotypes with specific spatio-
temporal patterns. In the unchallenged adult interfollicu-
lar epidermis, the three PPAR isotypes are undetectable,
whereas PPAR and PPAR are upregulated upon diverse
insults that result in both inflammation and cell prolifera-
tion. The use of mutant mice for each of the PPAR isotypes
helped in deciphering their specific role in vivo. Although
PPAR/	 mice do not present any phenotype, PPAR
null mice have a transient and initial delay in wound healing
and PPAR/	 mice exhibit a delay during the whole
healing process, postponing its completion by 2–3 d.
Differential expression of PPARs in the developing 
epidermis and during postnatal stages
Here we show that the three PPAR isotypes are expressed
during embryonic epidermal development, starting before
stratification and differentiation of the epidermis, and in
early postnatal stage, whereas they are below detection levels
in the adult interfollicular epidermis. PPAR and  were
also found to be present at low levels in the fetal dermis. This
distribution strongly suggests that PPARs are not required,
or only at very low levels, for normal skin homeostasis in the
adult, but participate in the fetal maturation and differentia-
tion of the skin. The reexpression of PPARs during wound
healing, with a similar overall pattern as seen during develop-
ment, provides a valuable experimental model. Indeed, it im-
plies that wound healing reactivates processes that are nor-
mally part of the developmental program rather than those
involved in normal adult skin renewal.
Figure 9. PPAR/	 primary kerati-
nocytes show impaired adhesion and 
migration properties. Primary kerati-
nocytes isolated from skin of PPAR/ 
(a–d) or PPAR/	 (e–h) newborn 
pups. (a) Wild-type keratinocytes 24 h 
after plating; (e) PPAR/	 kerati-
nocytes 3 d after plating. (b–d and f–h) 
Wounded cultures of primary kerati-
nocytes: scrape wounds were made at 
day 0 (day 0 corresponds to the obten-
tion of 70–80% confluent cell culture) 
(b and f). Panels c and g and d and h 
represent the wounds at day 2 and 4 
after scraping, respectively. Bar: (a, b, e, 
f, and insets) 100 m; (c, d, g, and h) 
200 m.
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Development of a functional barrier during late embry-
onic development (Hardman et al., 1998) correlates with
both changes in the organization and the abundance of the
extracellular lipid lamellar structures (Aszterbaum et al.,
1992; Hardman et al., 1998). This is in part reflected with
fetal keratohyalin granules, which contain large lipid-like
droplets (DuBrul, 1972). In the adult, the epidermis is con-
tinuously renewed through proliferation of the cells forming
the basal layer, and the daughter cells differentiate along mi-
gration to the upper cornified layer. No large lipid-like
droplets are seen, suggesting a difference in the lipid content
and organization with respect to the fetal skin. However, at
the molecular level the difference in the mechanisms in-
volved in the fetal and adult epidermis are poorly under-
stood. Thus, the different PPAR expression patterns might
be of high interest with respect to the molecular events un-
derlying the differences between fetal and adult epidermis.
Genetic analysis of specific roles of PPAR, , and  in 
skin maturation
PPAR activators accelerate rat epidermal development (Han-
ley et al., 1997b) and can increase the level of expression of
several keratinocyte terminal differentiation markers in rat
keratinocyte culture (Hanley et al., 1998). However, under
normal conditions, no altered skin phenotype has been de-
tected so far in PPAR null mice (Lee et al., 1995). Simi-
larly, no skin alteration was reported for the PPAR null
mouse, born after placental rescue using tetraploid cells
(Barak et al., 1999), and PPAR/	 mice appear normal as
well (herein and Kubota et al. [1999]). Finally, as mentioned
above, the PPAR null mice that we and others (Peters et
al., 2000) have obtained exhibit no obvious skin defect, and
the PPAR/	 mice appear normal as well. At this point,
it is of interest to note that most of the previous mutant
mouse lines, resulting from targeted disruption of nuclear
hormone receptors genes, failed to exhibit a skin phenotype
even though there is evidence for a role of these nuclear hor-
mone receptors in the skin. The absence of a skin phenotype
at birth in the various PPAR mutant mice might be due to a
functional redundancy of the three isotypes. Alternatively, as
with many processes during development, gene expression
in skin formation may depend on a regulatory network
rather than on a linear cascade, allowing for adaptation to
take place during in utero development. In adult skin, the
absence or below in situ hybridization detection level of
PPAR expression in interfollicular epidermis is consistent
with the absence of an altered skin in the mutant mice.
However, a careful histological observation and Ki67 quan-
tification indicated a small but reproducible amount of pro-
liferative cells in PPAR/	 mice, suggesting that even in
unchallenged condition, skin homeostasis is slightly altered
in the PPAR/	 mice.
PPAR and the inflammation stage in wound healing
Skin wound healing can be divided into three major overlap-
ping and interacting phases which follow a defined time se-
quence: inflammation, new tissue formation, including the
differentiation of a neoepithelium, and remodeling (Fig. 7).
The initial inflammatory phase after an injury is a beneficial
step that precedes normal repair of the wound. It allows clot
formation and control of infectious agents, favors vasculariza-
tion, and allows local afflux of growth factors. Attracted by
chemotactic factors and chemokines, neutrophils accumulate
first in the wound bed and serve as an initial line of defense
and source of proinflammatory cytokines. After neutrophils,
monocytes/macrophages are recruited and, in addition to pro-
viding an immune response, release large amounts of growth
factors and cytokines. If not controlled, inflammation can
contribute to pathological healing, such as extensive scarring
or fibrosis, which underscore the importance of a tight control
of this early phase of the healing process. The pattern of
PPAR expression, mainly in the very first days after the in-
jury nicely overlaps the timing of the inflammation stage. Ac-
cordingly, PPAR null mice exhibit a transient but significant
delay in the healing process in the early phase. Since we
showed that PPAR null mice exhibit normal keratinocyte
proliferation after TPA treatment of the dorsal epidermis, the
delay in the skin healing process of the PPAR null mice is
unlikely to be due to an uncontrolled proliferation. Moreover,
the quantification of the inflammatory infiltration shows
that the recruitment of the neutrophils and monocytes/
macrophages to the wound bed are both impaired in the
PPAR	/	 mice during the very early inflammatory phase.
This strongly suggests that the transient delay of healing
observed in the PPAR null mice is due to uncontrolled in-
flammation at the wound site. The normal recruitment of im-
mune cells is then restored in the PPAR	/	 mice, which re-
flects the ability of these mice to finally reestablish appropriate
inflammation control and, consequently, normal resolution of
the healing process. These data correlate with previous obser-
vations that PPAR participates in the control of an inflam-
matory response (Devchand et al., 1996; Staels et al., 1998).
At the molecular level, specific quantification of chemotactic
factors and chemokines released in the wound bed will help in
deciphering the mechanism, leading to altered recruitment of
immune cells in the PPAR null mice. Of particular interest
will be the measurement of the levels of IL-1 released at the
wound site. Indeed, several reports indicate that keratinocytes,
after a skin injury, may participate in the early inflammatory
phase by secreting large amounts of preformed active IL-1
(Kupper, 1990; Kupper and Groves, 1995). In this context, it is
certainly noteworthy that our results demonstrate that PPAR
expression is upregulated in the keratinocytes at the wound
edges during the inflammatory phase of skin wound healing.
In contrast, PPAR seems not to be involved in skin in-
flammation as it is not expressed in any of the models tested
in our study.
PPAR expression and keratinocyte proliferation, 
adhesion, and migration
In the second step of wound healing, which begins within
hours of a skin injury, the keratinocytes will start to migrate
from the wound edges and proliferate to cover the wound.
The final stage then consists of stratification and differentia-
tion of the neoepidermis and colonization of the epithelium
by the nonkeratinocyte cells (e.g., immune cells). Upregula-
tion of PPAR in the keratinocytes takes place during all
these successive processes. In addition, the reexpression of
PPAR in two models of intense keratinocyte prolifera-
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tion (TPA and hair plucking) strengthens the link between
PPAR and the control of cell proliferation. A role of
PPAR in the control of epithelial cell proliferation has also
been recently described in colon cancer cells (He et al.,
1999), whereas Matsuura et al. (1999) associated an increased
PPAR expression to induced human keratinocyte differenti-
ation in vitro and in vivo. Interestingly, our PPAR mutant
mice exhibit an altered control of keratinocyte proliferation,
characterized by a hyperproliferative reaction, in response to
TPA stimulation and hair plucking. No defect is observed in
PPAR/	 keratinocyte–terminal differentiation, as sug-
gested by the expression of keratinocyte differentiation mark-
ers. Consistent with these observations, an enhanced hyper-
plastic response, associated to a higher expression of cell cycle
proteins but normal expression of differentiation markers,
was reported recently in the epidermis of PPAR null mice
(Peters et al., 2000). In addition to this observation, and very
importantly, we also report a defect in PPAR mutant kera-
tinocyte adhesion and migration capacities, as observed in pri-
mary keratinocyte cultures. This result strongly suggests that
a keratinocyte migration defect is at least partially responsible
for the delay in the healing process in the PPAR/	 mice.
In the whole animal, indeed, quantification of the cells at the
edges of a wound indicates that the keratinocytes are slightly
more numerous in the PPAR mutant wounds, consistent
with an increased proliferation and slower migration of these
cells. Thus, although we cannot rule out a more general im-
plication of PPAR in the skin, our data, together with the
recently reported phenotype of the PPAR null mice, pro-
vide evidence for the necessity of an increased PPAR expres-
sion to control a well balanced proliferation/differentiation
process and efficient keratinocyte migration required for non-
pathological wound healing.
In conclusion, our observations reveal an important role of
PPAR and PPAR in epidermis repair. In addition and very
importantly, despite sharing many characteristics these two
isotypes clearly do not have redundant functions. Their re-
spective expression and function are complementary and cover
the different phases of skin wound–healing processes. Thus,
elucidation of the molecular mechanisms responsible for the
differential expression of PPAR in the various inflammation
models, as well as those leading to PPAR activation in the
proliferating stage and cessation of its activity upon comple-
tion of healing, should be very informative with respect to the
potential use of PPAR and PPAR agonists, or antagonists
when available, as therapeutic tools in skin affections.
Materials and methods
Tissue preparation and sections
Skin samples were embedded in tissue-freezing medium (Leica). 8-m cryo-
stat tissue sections were mounted on slides and postfixed in 4% parafor-
maldehyde-PBS (10 min, 4C). After washings in PBS, sections were used
either for histological staining (hematoxilin-eosin, Van Gieson [collagen])
or resorcin/fuchsine [elastin]) immunofluorescent labeling, or in situ hy-
bridization.
In situ hybridization
Mouse PPAR–, –, and –specific sense (S) and antisense (AS) digoxyge-
nin–labeled riboprobes were obtained by in vitro transcription, using
mouse PPAR , , or  A/B domain cDNA as a template (size of the probes:
PPAR AS, 230 b; PPAR S, 230 b; PPAR AS, 200 b; PPAR S, 170 b;
PPAR AS, 230 b; PPAR S, 222 b). The digoxygenin incorporation and the
specificity of the probes were tested on slot-blot hybridizations. In situ hy-
bridization was processed as described previously (Braissant et al., 1996).
Immunofluorescence
The keratin 6, 10, and 14 cytoskeletal protein (BabCo), loricrin (BabCo),
involucrin (BabCo), and the Ki67 nuclear antigen (Novo Castra) were de-
tected using rabbit polyclonal primary antibodies. For the Ki67 labeling,
an antigen-unmasking step was performed (citrate buffer, pH 6, 100C, 10
mn). The slides were then processed as followed: 1  PBS, 0.1% BSA/30
mn/RT; primary antibodies in 1  PBS buffer, 0.1% BSA/2 h/RT; washings
in 1  PBS buffer; FITC-conjugated goat anti–rabbit IgG secondary anti-
body (Sigma-Aldrich) in 1  PBS buffer, 0.1% BSA/1 h/RT. The slides were
subsequently washed and mounted before microscopic observation.
RNase protection assays
Mouse PPAR–, – and –specific antisense riboprobes were obtained by
in vitro transcription with the T7 or SP6 RNA polymerase, using mouse
PPAR (A/B domain),  or  (A/B/C domain) cDNA subcloned in the
pGEM3Zf() (Promega) as templates. The 228-bases PPAR probe, the
272-bases PPAR probe, and the 331-bases PPAR probe resulted in di-
gested fragments of 192, 254, and 295 bp, for PPAR, PPAR, and PPAR,
respectively. The L27 probe has been described previously (Lemberger et
al., 1994). For all PPAR probes, a ratio of 1:1 of 32-P–UTP to cold UTP
was used, whereas a 1:20 ratio of L27 probe was used. Incorporation
and specific activity of each probe was determined after purification via
Rneasy Clean-Up (QIAGEN).
Direct lysate RPA was carried out as described by the manufacturer
(Ambion) with some modifications. In brief, tissues were lysed in Lysis/De-
naturation solution (2 mg/ml) and clarified by centrifugation (Qiashredder;
QIAGEN). 20 L of lysate was hybridized to 1 ng of specific PPAR probes
(109 cpm/g) and 10 ng of L27 probe (108 cpm/g). RNase digestion (10
U/ml RNaseA; 400 U/ml RNaseT1) was carried out for all probes at 37C/
20 min. The products of RPA were resolved in a 6% electrolyte-gradient
denaturing polyacrylamide gel. Gels were dried and exposed on phosphor
screen of a StormImager 840 (Molecular Dynamics). Quantitative analysis
was performed by using IQuant 2.5 software. PPAR mRNA expression was
normalized to the previously calculated specific activity of the probe and
to L27 mRNA expression. The PPAR/L27 ratio was further normalized to
the UTP content of each PPAR probe.
Wound-healing experiments
The hair follicle cycle of each mouse was synchronized by shaving the
back of the animal 2 wk before starting the experiment. Control and trans-
genic mice were then anesthetized, shaved, and a full thickness middorsal
wound (0.5-cm2 surface, square shaped) was created by excising the skin
and the underlying panniculus carnosus. The wounds were then allowed
to dry and form a scab. Wound closure was measured daily in a double-
blinded fashion, on young (6–8 wk) and old (12–18 mo) animals until
complete healing of both control and transgenic mice. The surfaces of the
wounds were measured by a single individual by covering each wound
with a transparent plastic sheet and tracing the wound area on anesthe-
tized animals (Gross et al., 1995; Streit et al., 2000). Wound areas were
quantified (Sigma-Scan; Sigma-Aldrich) and were standardized and ex-
pressed as a percentage of the initial wound size (100%). The mean values
(n  8–10 animals) were plotted for each time point, 
 SEM. A Student’s t
test was used for comparison of the control and PPAR mutant groups.
To examine PPAR expression at the site of the injury, the mouse was
sacrificed and an area including the scab and the complete epithelial edges
of the wounds was excised at each time point. For each mouse, a control of
normal dorsal skin was taken at distance from the wounded tissue.
Inflammatory infiltration
Neutrophil and monocyte/macrophage infiltration was quantified on tissue
sections of PPAR/ and 	/	 mice. Sections from wounds at day 1, 3,
and 5 postwounding were hematoxilin/eosin stained. The density of neu-
trophils and monocytes/macrophages was determined by manually count-
ing the infiltrating immune cells based on morphological criteria in five
standardized microscopic fields (400 magnification) for each wound.
Statistical analysis of the data is based on the Student’s t test.
Keratinocyte proliferation assays
TPA application. 5 nmoles of TPA in 200 l ethanol was topically applied
on the shaved left part of the dorsal epidermis of control and transgenic an-
imals. As a control, the right part of the dorsal epidermis, away from the
TPA-treated part, was treated with vehicle only. Samples were harvested
2 d after the TPA application.
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Hair plucking. For synchronization purposes, hair was plucked a first
time on a 0.5-cm2 dorsal surface of control and transgenic mice. After a
period of 10 d, the same surface was plucked a second time and the
treated region was dissected 2 d later. As a control, skin samples were
taken at a distance from the plucked surface.
The dissected tissues were then processed as described above and used
for histological staining, immunolabeling, or in situ hybridization. Quanti-
tative analysis of the mean epidermal thickening and the Ki67-positive
cells was performed using the Object Image software.
Primary keratinocyte culture and in vitro scraping wound
Mouse keratinocytes were isolated from epidermis as reported by Hager et
al. (1999) with the following modifications: the epidermis was separated
from the dermis after overnight incubation at 4C in 2.5 U/ml of Dispase.
The epidermis was placed in a 50-ml centrifuge tube with 10 ml of kerati-
nocyte serum–free medium and the tube was given 50 firm shakes. Kerati-
nocytes were resuspended in keratinocyte serum–free medium containing
0.05 mM Ca2 and 0.1 ng/ml epidermal growth factor, and seeded at 2 
105 cells/cm2 for the wild-type keratinocytes, and at 4–6  105 cells/cm2
for the mutant keratinocytes. Keratinocytes were used after 2–3 passages.
For the scraping experiment, keratinocytes were cultured in a 60-mm
diameter tissue culture dish. At 70–80% confluency, a scrape (1.5–2
mm) was made (day 0) across the diameter using a cell scraper. At the indi-
cated time, pictures of the cells near the edges were taken until complete
closure of the scrape wound. In total, the cells were maintained in culture
for 2–3 wk, depending on their genotype.
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